tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Starbucks announces restructuring, CoreWeave expands OpenAI pact: Morning Buzz
PremiumThe FlyStarbucks announces restructuring, CoreWeave expands OpenAI pact: Morning Buzz
1M ago
Optimistic Buy Rating for Capricor Therapeutics Driven by Regulatory Progress and Strategic Positioning
Premium
Ratings
Optimistic Buy Rating for Capricor Therapeutics Driven by Regulatory Progress and Strategic Positioning
1M ago
Capricor approval on track for mid-2026, says JonesResearch
Premium
The Fly
Capricor approval on track for mid-2026, says JonesResearch
1M ago
Closing Bell Movers: Opendoor up 36% after management reshuffle
PremiumThe FlyClosing Bell Movers: Opendoor up 36% after management reshuffle
2M ago
Capricor Therapeutics files $300M mixed securities shelf
Premium
The Fly
Capricor Therapeutics files $300M mixed securities shelf
2M ago
Capricor Therapeutics responds to FDA posting of dermiocel CRL
Premium
The Fly
Capricor Therapeutics responds to FDA posting of dermiocel CRL
2M ago
Optimistic Buy Rating for Capricor Therapeutics Amid Regulatory Challenges and Strategic Alignments
PremiumRatingsOptimistic Buy Rating for Capricor Therapeutics Amid Regulatory Challenges and Strategic Alignments
3M ago
Capricor Therapeutics: Strong Financial Position and Strategic Initiatives Drive Buy Rating Despite Regulatory Challenges
Premium
Ratings
Capricor Therapeutics: Strong Financial Position and Strategic Initiatives Drive Buy Rating Despite Regulatory Challenges
3M ago
Capricor Therapeutics: Q2 2025 Financial and Strategic Update
Premium
Company Announcements
Capricor Therapeutics: Q2 2025 Financial and Strategic Update
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100